Company intelligence / Profile preview
Glycovax Pharma
Montreal, Quebec, Canadaglycovax.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Glycovax has advanced a novel glycoconjugate COVID‑19 vaccine candidate (GVX‑002) into a Phase 1 clinical trial. The company also develops semi-synthetic vaccines and monoclonal antibodies targeting cancers and infectious diseases. Its proprietary platforms enable rapid design and production of next-generation carbohydrate-based immunotherapies with improved efficacy and safety profiles.[5][6][7]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Semi-synthetic vaccines (glycoconjugate vaccines)Monoclonal antibodies (mAbs)Nanoparticles as drug delivery vehicles[1][6][7]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
National Research Council Canada (NRC) – licensing agreements for CRM197 protein, SLA adjuvant, *Pseudomonas* vaccine technology.Koranex Capital – co-founder/investor.JSS Medical Research – clinical research collaboration on trials.[4][7]
Beyond the preview
Go deeper on Glycovax Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glycovax Pharma.